Influence of anti-platelet drugs on platelet-vessel waif interacticnks

https://doi.org/10.1016/0262-1746(87)90143-0Get rights and content

Abstract

The influence of in vitro treatment of platelets with antiplatelet drugs on the interaction of these cells with the subendothelium was studied using citrated human blood obtained from normal control donors. Reconstituted blood following drug treatment was circulated thwaigh a special chamber which housed averted segments of de-ardothelialized rabbit aorta. The wall shear rate used in these studies was 800 sec−l. Surface coverage of platelets on the subsndothelium were morptrically evaluated. Aspirin, Ibuprofen, Prostaglandin El and 13 Azaprostanoic acid significantly reduced platelet thrombi an exposed sabendothelium. The calcium antagonists, Quin 2 and Diltiazem, exerted similar inhibitory effects, whereas Verapamil was a poor inhibitor. Aspirin treatment significantly enhanced platelet adhesion to the exposed vascular surface. Salicylate and Salicylamide did not enhance platelet. Only Aspirin enhanced the formation of lipcaygonase metabolites of radiolabeled arachidonate.Results suggest that drugs which inhibit platelet aggregation and seerertion of granule cot*Ants reduce formation of platelet thrombi. However, these drugs may or may not have a similar influence on platelet interaction with the subendathelium leading to spreading, adherence or formation of aggregates.

References (48)

  • G.H.R. Rao et al.

    Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with the Hermansky-Pudlak syndrome

    Prostaglandins and Medicine

    (1981)
  • M.E. Ring et al.

    Effects of oral Diltiazem on platelet function alone and in combination with ‘low dose’ aspirin

    Thrombosis Research

    (1986)
  • G.H.R. Rao et al.

    Irreversible platelet aggregation does not depend on lipocygenase metabolites

    Biochemical Biophysical Research Ocamsinicaticns

    (1985)
  • K.I. Shine et al.

    Pathophysiology of myocardial infarction

    Annals of Internal Medicine

    (1977)
  • M.A. DeWood et al.

    Prevalen:e of total coronary occlusion during the early hours of tranemural myocardial infarctions

    New England Journal. of Medicine

    (1980)
  • W.P.M. Fulton et al.

    Causal role of coronary thrembotic occlusion in myocardial infarction: Evidence of stereo-arteriography serial sections and autoradiography

    American Journal of Cardiology

    (1977)
  • J. Zahavi

    The role of platelets in myocardial infarction, ischemic heart disease, cardiovascular disease, thromboambolic disorders and acute idiopathic perioarditis

    Thrombosis and Haemostasis

    (1977)
  • M.B. Schwartz et al.

    Platelet aggregates in ischemic heart disease

    Thrombosis and Hasmostasis

    (1980)
  • R.I. Handin et al.

    Elevation of platelet factor four in acute myocardial infarction:Measurement by radioassay

    Journal of Laboratory Clinical Medicine

    (1978)
  • T. Mehta et al.

    Role of blood platelets and parostsglandins in the coronary artery disease

    American Journal of Cardiology

    (1981)
  • P.D. Hirsh et al.

    Release of Prostaglandins and thromboxans into the coronary circulation in patients with ischemic heart disease

    New England Journal of Medicine

    (1981)
  • A. Maseri et al.

    Pathogenetic medwniews underlying the clinical events associated with atherosclerrytic disease

    Circulation

    (1980)
  • Aspirin in coronary heart disease

    Journal of Chronic Diseases

    (1976)
  • A randomized controlled trial of aspirin in perscne recovered from medial infarction

    Journal of the American Medical Association

    (1980)
  • Cited by (0)

    View full text